scispace - formally typeset
A

Ayman Koteish

Researcher at Johns Hopkins University

Publications -  32
Citations -  3179

Ayman Koteish is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Fatty liver & Liver disease. The author has an hindex of 19, co-authored 29 publications receiving 2847 citations. Previous affiliations of Ayman Koteish include Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

TL;DR: The results extend previous national estimates of the prevalence of NAFLD in the US population and highlight the burden of this disease, which is more common in men, Mexican Americans, and people with diabetes and obesity are the most affected groups.
Journal ArticleDOI

Animal models of steatosis.

TL;DR: Animals with genetic or environmental induction of hepatic lipogenesis appear to be useful models for human nonalcoholic fatty liver disease in which hyperinsulinemia and defective leptin signaling are conspicuous at early stages of the disease process.
Journal ArticleDOI

Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro

TL;DR: It is shown that TGF-β1 induces an epithelial-to-mesenchymal transition (EMT) state in mature hepatocytes in vitro, and a potentially crucial role for EMT in the development and progression of hepatic fibrogenesis is supported.
Journal ArticleDOI

Impaired liver regeneration in inducible nitric oxide synthasedeficient mice

TL;DR: It is reported that the hepatocyte proliferative response to partial liver resection is severely inhibited in transgenic mice with targeted disruption of the iNOS gene, suggesting that during successful tissue regeneration, injury-related cytokines induce factors, such as iN OS and its product, NO, that protect surviving cells from cytokine-mediated death.
Journal ArticleDOI

Meta‐analysis: vitamin D and non‐alcoholic fatty liver disease

TL;DR: Non‐alcoholic fatty liver disease (NAFLD) is a highly prevalent condition and emerging evidence suggests that vitamin D may play a role in the pathogenesis of NAFLD.